Otsuka's Alzheimer's agitation drug hits the mark - PMLiVE

Otsuka's Alzheimer's agitation drug hits the mark  PMLiVEOtsuka has reported positive phase 3 results with a drug intended to calm agitation in patients with Alzheimer's disease. The first trial readout from the ...